NCLEX Chronic Illness Practice Questions Related

Review NCLEX Chronic Illness Practice Questions related questions and content

The mechanism of action of Rosiglitazone is a

  • A. Insulin releasing agent
  • B. PPAR γ agonist
  • C. Increases cellular uptake of glucose
  • D. Reduces release of insulin
Correct Answer: B

Rationale: Rosiglitazone's PPAR γ agonist flips gene switches, boosts insulin sensitivity, a chronic cell tweak. It's not an insulin releaser, direct uptake driver, or suppressor sulphonylureas release, metformin ups uptake, none cut insulin. Pharmacists bank on this, a sensitivity shift for type 2's root.